Literature DB >> 809500

Pseudomonas aeruginosa infection in hospital: a comparison between 'infective' and 'environmental' strains.

A H Al-Dujaili, D M Harris.   

Abstract

One hundred and fifty-six infections or episodes of infection associated with Pseudomonas aeruginosa in six hospitals over 14 months were investigated. Pyocine typing and serotyping suggested that 145 distinct episodes had occurred, caused by 78 different strains. During this period 15 distinct strains were isolated from the environment at one of the hospitals; 12 of these were apparently unassociated with infection in the same ward during the period, and 4 were of types not encountered in infective processes at any hospital. There appeared to be a rather higher proportion of unclassifiable pyocine inhibition patterns among the environmental strains; in general these strains also produced smaller amounts of haemolysin. If failure to produce haemolysin in vitro is correlated with lack of virulence in vivo, this may partially explain the sporadic nature of hospital infection with Ps. aeruginosa, despite the prevalence of strains of this species in the environment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809500      PMCID: PMC2130302          DOI: 10.1017/s0022172400047227

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  10 in total

1.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

2.  Sources of Pseudomonas aeruginosa infection in a respiratory-surgical intensive-therapy unit.

Authors:  D Teres; P Schweers; L S Bushnell; J Hedley-Whyte; D S Feingold
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

3.  Studies on the virulence of hospital strains of Pseudomonas aeruginosa.

Authors:  K M Klyhn; R H Gorrill
Journal:  J Gen Microbiol       Date:  1967-05

4.  Typing of Pseudomonas pyocyanea by pyocine production.

Authors:  R R Gillies; J R Govan
Journal:  J Pathol Bacteriol       Date:  1966-04

5.  Evaluation of commercially available antisera for serotyping of Pseudomonas aeruginosa.

Authors:  A H Al-Dujaili; D M Harris
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

6.  Sources of infection with Pseudomonas aeruginosa in patients with tracheostomy.

Authors:  E J Lowbury; B T Thom; H A Lilly; J R Babb; K Whittall
Journal:  J Med Microbiol       Date:  1970-02       Impact factor: 2.472

7.  Identification of Pseudomonas aeruginosa in the clinical laboratory.

Authors:  I Phillips
Journal:  J Med Microbiol       Date:  1969-02       Impact factor: 2.472

8.  Further studies in the pyocine typing of Pseudomonas pyocyanea.

Authors:  J R Govan; R R Gillies
Journal:  J Med Microbiol       Date:  1969-02       Impact factor: 2.472

9.  Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient.

Authors:  R A Shooter; K A Walker; V R Williams; G M Horgan; M T Parker; E H Asheshov; J F Bullimore
Journal:  Lancet       Date:  1966-12-17       Impact factor: 79.321

10.  FACTORS THAT INFLUENCE TOXIGENICITY OF PSEUDOMONAS AERUGINOSA.

Authors:  P V LIU
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

  10 in total
  7 in total

1.  Cloning and characterization of the hemolysin determinants from Vibrio cholerae RV79(Hly+), RV79(Hly-), and 569B.

Authors:  S L Goldberg; J R Murphy
Journal:  J Bacteriol       Date:  1985-04       Impact factor: 3.490

2.  Aberrant form of Pseudomonas aeruginosa in sputum and cerebrospinal fluid causing infection in a compromised patient.

Authors:  J Middleton; H Chmel
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

3.  Toxic activity against alveolar macrophages of products of Pseudomonas aeruginosa isolated from respiratory and non-respiratory sites.

Authors:  A H Al-Dujaili
Journal:  J Hyg (Lond)       Date:  1976-10

4.  Epidemiology of Pseudomonas aeruginosa infections: determination by pyocin typing.

Authors:  F N Bruun; G J McGarrity; W S Blakemore; L L Coriell
Journal:  J Clin Microbiol       Date:  1976-03       Impact factor: 5.948

5.  The distribution of Bacteroides fragilis serotypes amongst clinical strains.

Authors:  K M Elhag; S Tabaqchali
Journal:  J Hyg (Lond)       Date:  1978-08

6.  Cloning, and expression in Escherichia coli K-12, of the chromosomal hemolysin (phospholipase C) determinant of Pseudomonas aeruginosa.

Authors:  K Coleman; G Dougan; J P Arbuthnott
Journal:  J Bacteriol       Date:  1983-02       Impact factor: 3.490

7.  A novel Pseudomonas aeruginosa bacteriophage, Ab31, a chimera formed from temperate phage PAJU2 and P. putida lytic phage AF: characteristics and mechanism of bacterial resistance.

Authors:  Libera Latino; Christiane Essoh; Yann Blouin; Hoang Vu Thien; Christine Pourcel
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.